Omeros Corporation was founded in Washington. The company is advancing several development projects focusing on diseases and disorders associated with the complement system, a specialized set of proteins that prevent invasion of pathogens as well as damaged cells in the body and are an important part of the human immune system. When triggered, the various components of the complement synergistically produce an immune response that fights infection and removes damaged or dead cells, maintaining the healthy function of the body's systems. However, dysregulation of the complement system (i.e., overactivation or underactivation) can be harmful and is associated with increased vulnerability to infectious and non-infectious diseases, including autoimmune diseases, chronic inflammation, thrombotic microangiopathy, and cancer. 

OMER

OMER Profile